Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Hancock Jaffe Laboratories

Hancock Jaffe Laboratories
1987 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
HJLI STOCK SYMBOL
$0.66 SHARE PRICE (As of Friday Closing)
Description

Hancock Jaffe Laboratories Inc development stage medical device company. It develops and sells biological tissue solutions to treat patients with coronary, vascular, end-stage renal and peripheral arterial diseases in the United States and Europe. The company develops and manufactures implantable cardiovascular bioprosthetic devices. Its key products include Bioprosthetic Heart Valve, CoreoGraft- Bypass Graft, and the Venous Valve.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Surgical Devices
Stock Exchange
NAS
Primary Office
  • 70 Doppler
  • Irvine, CA 92618
  • United States

+1 (949) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Hancock Jaffe Laboratories’s full profile, request a free trial.

Hancock Jaffe Laboratories Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.64 - $3.45 $11.8M $0.70 -$0.44 75.8K 17.9M

Hancock Jaffe Laboratories Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 16,942 13,094
Revenue 103 187 422 786
EBITDA (6,574) (6,048) (5,733) (5,379)
Net Income (6,770) (13,043) (7,791) (3,387)
Total Assets 7,253 3,559 2,215 1,783
Total Debt 989 0 2,619 633
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hancock Jaffe Laboratories Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Hancock Jaffe Laboratories‘s full profile, request access.

Request full access to PitchBook

Hancock Jaffe Laboratories Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RTI Surgical Formerly PE-Backed Alachua, FL 000 00000 000000000 00000
0000000000000 Corporation New York, NY 000 000000 - 000
00000000 0000000 Corporate Backed or Acquired Wixom, MI 000 00000 000000000 00000
0000 0000000 Formerly PE-Backed Harrison, NY 000 0000 00000000 0000
0000000 Private Equity-Backed Yokneam, Israel 0000 00000 000000000000 00000
To view this company’s complete list of competitors, request access »

Hancock Jaffe Laboratories Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Hancock Jaffe Laboratories‘s full profile, request access.

Request full access to PitchBook

Hancock Jaffe Laboratories Executive Team (9)

Name Title Board
Seat
Contact
Info
Robert Berman JD Chief Executive Officer & Board Member
Robert Rankin Chief Financial Officer & Chief Accounting Officer
William Abbott Co-Chief Financial Officer
Benedict Broennimann MD Executive
Marc Glickman MD Chief Medical Officer & Senior Vice President

4 Former Executives

You’re viewing 5 of 9 executives. Get the full list »

Hancock Jaffe Laboratories Board Members (5)

Name Representing Role Since Contact
Info
Gennady Alferenko Hancock Jaffe Laboratories Board Member 000 0000
Robert Berman JD Hancock Jaffe Laboratories Chief Executive Officer & Board Member 000 0000
Yuri Zhivilo Hancock Jaffe Laboratories Chairman 000 0000

2 Former Board Members

You’re viewing 3 of 5 board members. Get the full list »